Levodropropizine

DB12472InvestigationalSmall molecule

Levodropropizine is a peripherally-acting antitussive agent. Levodropropizine is under investigation in clinical trial NCT01573663 (A Drug-Drug Interaction Study of Ambroxol and Levodropropizine).

Chemical structure of Levodropropizine
Formula / weight
C13H20N2O2 · 236.315 g/mol (avg)

Resolves to

Compound
UNII3O31P6T4G3CAS99291-25-5ChEMBLCHEMBL1288810ChEBI82722PubChem65859
Clinical / RWD
RxNorm52014ATCR05DB27
Structure
InChIKeyPTVWPYVOOKLBCG-ZDUSSCGKSA-NSMILES[H][C@@](O)(CO)CN1CCN(CC1)C1=CC=CC=C1

What you can answer from here — as of May 27, 2021

7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
6ContraindicationsEach with its own population and attribute set
Sign in
85Marketed productsAcross 6 countries and 43 labellers
Sign in
1ATC codeIncluding every combination product, plus 6 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Levodropropizine, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In